USA flag logo/image

An Official Website of the United States Government

Fascia Lata Xenograft for ACL Replacement

Award Information

Agency:
Department of Health and Human Services
Branch:
N/A
Award ID:
29164
Program Year/Program:
1995 / SBIR
Agency Tracking Number:
29164
Solicitation Year:
N/A
Solicitation Topic Code:
N/A
Solicitation Number:
N/A
Small Business Information
CRYOLIFE, INC.
1655 ROBERTS BLVD, NW KENNESAW, GA 30144
View profile »
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
 
Phase 1
Fiscal Year: 1995
Title: Fascia Lata Xenograft for ACL Replacement
Agency: HHS
Contract: 1 R43 AR43054-01A1,
Award Amount: $91,680.00
 

Abstract:

Autologous patellar tendon grafts are the current gold standard for replacement of irreparable anteligaments. Allogeneic tissue grafts are the only accepted alternative to autologous grafts and theysupply. We will develop a non-immunogenic bovine fascia lata as a graft material for anterior cruciagrafts will be rendered non-immunogenic by in vitro processing. The resulting collagen tissue matrixbiomechanically sound, and will act as a scaffold for recipient fibroblast repopulation. These approprocessing will avoid use of materials which may have been responsible for effusions in the knees ofbovine xenografts. In Phase I of this project we will optimize methods for removal of cells and solufascia lata and determine immunogenicity by subcutaneous implantation in rabbits. We will prepare aapplication in which bovine fascia lata is assessed as an anterior cruciate ligament replacement inprocedures and instruments for implantation and fixation of fascia lata grafts are already availablepreviously been developed for implantation of allogeneic fascia lata.

Principal Investigator:

Steven Goldstein
40452

Business Contact:

Small Business Information at Submission:

Cryolife, Inc.
2211 New Market Parkway, Suite Marietta, GA 30067

EIN/Tax ID:
DUNS: N/A
Number of Employees: N/A
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No